Intl Society Of Pharmacoeconomics And Outcomes Research Inc
- Assets
- $27.2m
- Revenue
- $18.5m
- Investments
- $0.0
- Employees
- 65
- Location
- Lawrenceville, NJ
- Founding
- 10/1995
- Data as of
- 12/2023
- EIN
- 22-3369741
Organization Overview
Intl Society Of Pharmacoeconomics And Outcomes Research Inc is located in Lawrenceville, NJ. The organization was established in 1995. According to its NTEE Classification (H02) the organization is classified as: Management & Technical Assistance, under the broad grouping of Medical Research and related organizations. As of 12/2023, Intl Society Of Pharmacoeconomics And Outcomes Research Inc employed 65 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Intl Society Of Pharmacoeconomics And Outcomes Research Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2023, Intl Society Of Pharmacoeconomics And Outcomes Research Inc generated $18.5m in total revenue. This represents relatively stable growth, over the past 8 years the organization has increased revenue by an average of 6.4% each year. All expenses for the organization totaled $17.2m during the year ending 12/2023. While expenses have increased by 7.3% per year over the past 8 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990T
Mission & Program ActivityExcerpts From the 990T Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
PROMOTE GLOBAL HEALTH ECONOMICS AND OUTCOMES RESEARCH EXCELLENCE TO IMPROVE DECISION MAKING
Describe the Organization's Program Activity:
ISPOR IS A NON-PROFIT GLOBAL SCIENTIFIC AND EDUCATIONAL ORGANIZATION WITH APPROXIMATELY 9,296 MEMBERS, WHO ARE INVOLVED IN HEALTHCARE OUTCOMES RESEARCH (INCLUDING CLINICAL, ECONOMIC AND PATIENT-REPORTED OUTCOMES) OF HEALTH TECHNOLOGIES (DRUGS, DEVICES, DIAGNOSTICS) AND SERVICES OR THE USE OF OUTCOMES RESEARCH IN HEALTHCARE DECISIONS. THE MISSION OF ISPOR IS TO PROMOTE HEALTH ECONOMICS AND OUTCOMES RESEARCH EXCELLENCE TO IMPROVE DECISION MAKING FOR HEALTH GLOBALLY. ISPOR IS FUNDED THROUGH ITS MEETINGS, TRAINING COURSES AND MEMBERSHIP DUES. THROUGH ITS MULTIPLE MEETINGS EACH YEAR, ISPOR PROVIDES A FORUM TO FACILITATE THE INTERCHANGE OF SCIENTIFIC KNOWLEDGE IN PHARMACOECONOMICS /HEALTH ECONOMICS AND OUTCOMES RESEARCH, HEALTH POLICY AND THE USE OF THIS RESEARCH IN HEALTHCARE DECISIONS.ISPOR PUBLISHES TWO SCIENTIFIC JOURNALS, ONE HEOR NEWS MAGAZINE, AND FOUR ELECTRONIC NEWSLETTERS. ISPOR DEVELOPS CONSENSUS DOCUMENTS (GOOD PRACTICES/GUIDELINES) ON OUTCOMES RESEARCH METHODS OR USE OF THIS RESEARCH IN HEALTHCARE DECISIONS. ISPOR FOSTERS EDUCATION AND THE DEVELOPMENT OF OUTCOMES RESEARCH AT THE LOCAL LEVEL WITH ITS REGIONAL CHAPTERS AND STUDENT CHAPTERS GLOBALLY TO PROMOTE THE SCIENCE OF PHARMACOECONOMICS/HEALTH ECONOMICS AND HEALTH OUTCOMES RESEARCH WORLDWIDE. IN 2023, ISPOR HOSTED THREE IN-PERSON CONFERENCES: THE INTERNATIONAL CONFERENCE AND REAL-WORLD EVIDENCE SUMMIT IN BOSTON, AND THE EUROPEAN CONFERENCE IN COPENHAGEN, FEATURING OVER 5,200 SCIENTIFIC PRESENTATIONS. WE ALSO PUBLISHED 3,778 PAGES OF OUTCOMES RESEARCH AND HEALTH POLICY PAPERS IN OUR JOURNALSVALUE IN HEALTH, VALUE IN HEALTH REGIONAL ISSUES, AND VALUE & OUTCOMES SPOTLIGHT.OUR GLOBAL REACH IS EVIDENT IN OUR 7,775 MEMBERS FROM 99 COUNTRIES, 136 STUDENT CHAPTERS, AND 84 REGIONAL CHAPTERS. THROUGH ISPOR TASK FORCES, COUNCILS, AND SPECIAL INTEREST GROUPS, ISPOR ALSO DEVELOPS CONSENSUS GUIDELINES ON OUTCOMES RESEARCH METHODS AND THE APPLICATION OF THIS RESEARCH IN HEALTHCARE DECISIONS. OUR TOOLS FOR RESEARCHERS, SUCH AS THE GOOD PRACTICES FOR OUTCOMES RESEARCH, ARE WIDELY UTILIZED, WITH OVER 1,000,000 DOWNLOADS ANNUALLY, AND OUR WEB-BASED DATABASE CONTAINS OVER 74,000 RESEARCH PRESENTATIONS FROM ISPOR MEETINGS. THROUGH THESE EFFORTS, ISPOR FOSTERS THE EDUCATION AND DEVELOPMENT OF OUTCOMES RESEARCH WORLDWIDE.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Nancy S Berg CEO & Executive Director | OfficerTrustee | 40 | $257,968 |
Jan Elias Hanson PHD Past President (since July 2023) | OfficerTrustee | 2 | $0 |
Brian O'rourke President (since July 2023) | OfficerTrustee | 2 | $0 |
Sean Sullivan Msc PHD Treasurer | OfficerTrustee | 2 | $0 |
David Thompson PHD Director (until 6/30/23) | Trustee | 2 | $0 |
Eberechukwu Onukwugha Ms PHD President-Elect (since July 2023) | OfficerTrustee | 2 | $0 |
Outside Vendors & Contractors
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
Freeman Audio Visual | 12/30/23 | $574,299 |
Levy Premium Food Service Catering And Service | 12/30/23 | $506,089 |
Venable Llp Legal Services | 12/30/23 | $387,635 |
Taft Communications Llc Marketing/communication | 12/30/23 | $313,815 |
Richard J Willke Scientific Consulting | 12/30/23 | $298,282 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $25,000 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $25,000 |
| Total Program Service Revenue | $18,800,930 |
| Investment income | $556,459 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $55,851 |
| Net Gain/Loss on Asset Sales | -$958,799 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $18,483,761 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $0 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $887,460 |
| Compensation of current officers, directors, key employees. | $224,096 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $5,144,095 |
| Pension plan accruals and contributions | $233,080 |
| Other employee benefits | $484,072 |
| Payroll taxes | $618,439 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $324,755 |
| Fees for services: Accounting | $222,012 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $77,493 |
| Fees for services: Other | $717,728 |
| Advertising and promotion | $0 |
| Office expenses | $1,096,366 |
| Information technology | $0 |
| Royalties | $0 |
| Occupancy | $96,447 |
| Travel | $0 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $4,135,001 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $272,933 |
| Insurance | $46,731 |
| All other expenses | $870,802 |
| Total functional expenses | $17,227,897 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $2,187,171 |
| Savings and temporary cash investments | $625,004 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $950,871 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $502,442 |
| Net Land, buildings, and equipment | $2,806,687 |
| Investments—publicly traded securities | $20,165,756 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $0 |
| Total assets | $27,237,931 |
| Accounts payable and accrued expenses | $1,422,347 |
| Grants payable | $0 |
| Deferred revenue | $1,461,285 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $7,390 |
| Total liabilities | $2,891,022 |
| Net assets without donor restrictions | $24,346,909 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $27,237,931 |